Clinical Trials Directory

Trials / Conditions / Glomerular Disease

Glomerular Disease

17 registered clinical trials studyying Glomerular Disease — 6 currently recruiting.

StatusTrialSponsorPhase
Not Yet RecruitingEfficacy and Safety Study of HS-10542 for IgA Nephropathy
NCT07474636
Jiangsu Hansoh Pharmaceutical Co., Ltd.Phase 2
RecruitingOpen-label Extension Study of Zigakibart in Adults With IgA Nephropathy.
NCT06858319
Novartis PharmaceuticalsPhase 3
UnknownPodocyts Integrity in Glomerular Diseases
NCT05875454
Assiut University—
RecruitingInterview Study of Adult and Child Patients and Parents of Children With Swelling Due to Nephrotic Syndrome.
NCT05505500
University of Michigan—
UnknownStudy of Safety and Efficacy of ANG-3070 in Chronic Kidney Disease
NCT04939116
Angion Biomedica CorpPhase 2
CompletedImproving Scientific Rigor of Renal Clinical Endpoints for Sickle Cell Anemia
NCT04380610
University of Alabama at Birmingham—
CompletedSafety and Efficacy Study of VIS649 for IgA Nephropathy
NCT04287985
Visterra, Inc.Phase 2
TerminatedEffect of Moderate Caloric Restriction on Glomerular Growth After Kidney Transplantation
NCT03607500
University of MichiganN/A
RecruitingThe Impact of Glomerular Disorders on Bone Quality and Strength
NCT04528446
Columbia University—
RecruitingKOrea Renal Biobank NEtwoRk System TOward NExt-generation Analysis
NCT03929887
Seoul National University Hospital—
UnknownEffect of Glucocorticoids on Inflammation and Bone Metabolism in Patients With Glomerular Disease
NCT04987450
Medical University of Lodz—
UnknownLow Dose Steroids in the Treatment of Nephrotic Syndrome Relapse
NCT02216747
Rabin Medical CenterPhase 4
CompletedVitamin D Supplementation in Glomerular Disease
NCT01835639
Children's Hospital of PhiladelphiaN/A
RecruitingRituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy
NCT00977977
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)Phase 2
CompletedTRK-100STP Clinical Study - Chronic Renal Failure (Primary Glomerular Disease/Nephrosclerosis)
NCT01090037
Toray Industries, IncPhase 2 / Phase 3
CompletedKidney Disease Biomarkers
NCT00255398
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)—
CompletedPathogenesis of Glomerulosclerosis
NCT00001392
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)—